Browse > Article

Depression and Executive Dysfunction in Stroke  

Na, Kyoung-Sae (Department of Psychiatry, College of Medicine, Soonchunhyang University, Bucheon Hospital)
Kim, Shin-Gyeom (Department of Psychiatry, College of Medicine, Soonchunhyang University, Bucheon Hospital)
Lee, Soyoung Irene (Department of Psychiatry, College of Medicine, Soonchunhyang University, Bucheon Hospital)
Jung, Han-Yong (Department of Psychiatry, College of Medicine, Soonchunhyang University, Bucheon Hospital)
Publication Information
Korean Journal of Biological Psychiatry / v.19, no.4, 2012 , pp. 179-186 More about this Journal
Abstract
Depression and executive dysfunction are common neuropsychiatric sequelae of stroke. Patients with stroke are more predisposed to depression and executive dysfunction compared to patients with similar degree of physical disability. Both depression and executive dysfunction are also associated with poor prognosis such as high mortality and delayed recovery after stroke. Complex neurobiological and anatomical mechanisms are associated with the development of depression and executive dysfunction after stroke. Activation of pro-inflammatory cytokines is thought to be associated with onset of depression, whereas injuries in frontal-subcortical circuit are thought to be a link between depression and executive dysfunction. Early detection of depressive symptoms and both pharmacological and non-pharmacological treatment would be helpful. In this review paper, the authors investigated 1) biological and neuroanatomical substrate for poststroke depression and executive dysfunction, 2) the relationship and common etiopathology for poststroke depression and executive dysfunction, and 3) pharmacological and non-pharmacological treatment for poststroke depression. The contents of the paper are as follows : the prevalence, clinical manifestation, and biological etiology for poststroke depression, neuroanatomical abnormalities as a common etiological factor for depression and executive dysfunction, pharmacotherapy and non-pharmacological approach.
Keywords
Stroke; Depression; Executive dysfunction; Antidepressant;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alexopoulos GS. Role of executive function in late-life depression. J Clin Psychiatry 2003;64 Suppl 14:18-23.
2 Lockwood KA, Alexopoulos GS, van Gorp WG. Executive dysfunction in geriatric depression. Am J Psychiatry 2002;159:1119-1126.   DOI   ScienceOn
3 Bour A, Rasquin S, Limburg M, Verhey F. Depressive symptoms and executive functioning in stroke patients: a follow-up study. Int J Geriatr Psychiatry 2011;26:679-686.   DOI   ScienceOn
4 Cui X, Lyness JM, Tu X, King DA, Caine ED. Does depression precede or follow executive dysfunction? Outcomes in older primary care patients. Am J Psychiatry 2007;164:1221-1228.   DOI   ScienceOn
5 Melkas S, Vataja R, Oksala NK, Jokinen H, Pohjasvaara T, Oksala A, et al. Depression-executive dysfunction syndrome relates to poor poststroke survival. Am J Geriatr Psychiatry 2010;18:1007-1016.   DOI   ScienceOn
6 Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, et al. Depression after stroke and lesion location: a systematic review. Lancet 2000;356:122-126.   DOI   ScienceOn
7 Vataja R, Pohjasvaara T, Leppavuori A, Mantyla R, Aronen HJ, Salonen O, et al. Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry 2001;58:925-931.   DOI   ScienceOn
8 Bolla-Wilson K, Robinson RG, Starkstein SE, Boston J, Price TR. Lateralization of dementia of depression in stroke patients. Am J Psychiatry 1989;146:627-634.   DOI
9 Spalletta G, Guida G, De Angelis D, Caltagirone C. Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness. J Neurol 2002;249:1541-1551.   DOI   ScienceOn
10 Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatry 2010;55:341-349.   DOI
11 Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2003;250:347-351.   DOI   ScienceOn
12 Rasmussen A, Lunde M, Poulsen DL, Sorensen K, Qvitzau S, Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003;44:216-221.   DOI   ScienceOn
13 Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299:2391-2400.   DOI   ScienceOn
14 Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010;67:187-196.   DOI   ScienceOn
15 Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: Results from a randomized placebo-controlled trial. J Clin Psychiatry 2006;67:1104-1109.   DOI   ScienceOn
16 Palomaki H, Kaste M, Berg A, Lonnqvist R, Lonnqvist J, Lehtihalmes M, et al. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 1999;66:490-494.   DOI   ScienceOn
17 Bondareff W, Alpert M, Friedhoff AJ, Richter EM, Clary CM, Batzar E. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000;157:729-736.   DOI   ScienceOn
18 Lincoln NB, Flannaghan T. Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke 2003;34:111-115.   DOI   ScienceOn
19 Grigsby J, Kaye K, Baxter J, Shetterly SM, Hamman RF. Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J Am Geriatr Soc 1998;46:590-596.   DOI
20 Lincoln NB, Flannaghan T, Sutcliffe L, Rother L. Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil 1997;11:114-122.   DOI   ScienceOn
21 Rasquin SM, Van De Sande P, Praamstra AJ, Van Heugten CM. Cognitive-behavioural intervention for depression after stroke: five single case studies on effects and feasibility. Neuropsychol Rehabil 2009;19:208-222.   DOI   ScienceOn
22 Mohlman J, Gorman JM. The role of executive functioning in CBT: a pilot study with anxious older adults. Behav Res Ther 2005;43:447-465.   DOI   ScienceOn
23 Watkins CL, Auton MF, Deans CF, Dickinson HA, Jack CI, Lightbody CE, et al. Motivational interviewing early after acute stroke: a randomized, controlled trial. Stroke 2007;38:1004-1009.   DOI   ScienceOn
24 Smith J, Forster A, House A, Knapp P, Wright J, Young J. Information provision for stroke patients and their caregivers. Cochrane Database Syst Rev 2008:CD001919.
25 Williams LS, Kroenke K, Bakas T, Plue LD, Brizendine E, Tu W, et al. Care management of poststroke depression: a randomized, controlled trial. Stroke 2007;38:998-1003.   DOI   ScienceOn
26 Di Carlo A, Launer LJ, Breteler MM, Fratiglioni L, Lobo A, Martinez-Lage J, et al. Frequency of stroke in Europe: A collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology 2000;54(11 Suppl 5):S28-S33.
27 Maes M. Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr Opin Psychiatry 2009;22:75-83.   DOI   ScienceOn
28 Aben I, Verhey F, Strik J, Lousberg R, Lodder J, Honig A. A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry 2003;74:581-585.   DOI   ScienceOn
29 Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54:376-387.   DOI   ScienceOn
30 Folstein MF, Maiberger R, McHugh PR. Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 1977;40:1018-1020.   DOI
31 Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodegenerative (I & ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009;24:27-53.   DOI   ScienceOn
32 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association;1994.
33 Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993;150:124-129.   DOI
34 Lenzi GL, Altieri M, Maestrini I. Post-stroke depression. Rev Neurol (Paris) 2008;164:837-840.   DOI   ScienceOn
35 Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke. A community study of its frequency. Br J Psychiatry 1987;151:200-205.   DOI   ScienceOn
36 Muller N, Schwarz MJ. COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des 2008;14:1452-1465.   DOI   ScienceOn
37 Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005;12:255-269.   DOI   ScienceOn
38 Loftis JM, Huckans M, Morasco BJ. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 2010;37:519-533.   DOI   ScienceOn
39 Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 1998;62:583-606.   DOI   ScienceOn
40 Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011;52:1922-1929.   DOI   ScienceOn
41 Dobos N, de Vries EF, Kema IP, Patas K, Prins M, Nijholt IM, et al. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J Alzheimers Dis 2012;28:905-915.
42 Gabbay V, Klein RG, Katz Y, Mendoza S, Guttman LE, Alonso CM, et al. The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry 2010;51:935-943.   DOI   ScienceOn
43 Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-741.   DOI   ScienceOn
44 Na KS, Kim YK. Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology 2007;56:55-63.   DOI   ScienceOn
45 Lyons KE, Zelazo PD. Monitoring, metacognition, and executive function: elucidating the role of self-reflection in the development of self-regulation. Adv Child Dev Behav 2011;40:379-412.
46 Broomfield NM, Laidlaw K, Hickabottom E, Murray MF, Pendrey R, Whittick JE, et al. Post-stroke depression: the case for augmented, individually tailored cognitive behavioural therapy. Clin Psychol Psychother 2011;18:202-217.   DOI   ScienceOn
47 Royall DR, Lauterbach EC, Cummings JL, Reeve A, Rummans TA, Kaufer DI, et al. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002;14:377-405.   DOI   ScienceOn
48 Duke LM, Kaszniak AW. Executive control functions in degenerative dementias: a comparative review. Neuropsychol Rev 2000;10:75-99.   DOI   ScienceOn
49 Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-880.   DOI   ScienceOn
50 Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain 1995;118(Pt 1):279-306.   DOI   ScienceOn
51 Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, et al. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry 2009;66:478-486.   DOI   ScienceOn
52 Campbell JJ 3rd, Coffey CE. Neuropsychiatric significance of subcortical hyperintensity. J Neuropsychiatry Clin Neurosci 2001;13:261-288.   DOI   ScienceOn
53 van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991;114(Pt 2):761-774.   DOI
54 Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-659.   DOI   ScienceOn
55 Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, et al. Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study. Cerebrovasc Dis 2009;27:384-391.   DOI   ScienceOn
56 Radanovic M, Mansur LL, Azambuja MJ, Porto CS, Scaff M. Contribution to the evaluation of language disturbances in subcortical lesions: a pilot study. Arq Neuropsiquiatr 2004;62:51-57.   DOI   ScienceOn
57 Frisoni GB, Galluzzi S, Bresciani L, Zanetti O, Geroldi C. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J Neurol 2002;249:1423-1432.   DOI   ScienceOn
58 Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2002;72:217-220.   DOI   ScienceOn
59 Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.   DOI
60 O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002;59:321-326.   DOI   ScienceOn
61 Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 2008;79:619-624.
62 Greenwald BS, Kramer-Ginsberg E, Krishnan RR, Ashtari M, Aupperle PM, Patel M. MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1996;153:1212-1215.   DOI
63 de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-151.   DOI   ScienceOn
64 Vataja R, Pohjasvaara T, Leppavuori A, Mantyla R, Aronen HJ, Salonen O, et al. Magnetic resonance imaging correlates of depression after ischemic stroke. Archives of general psychiatry 2001;58:925-931.   DOI   ScienceOn
65 Pariel-Madjlessi S, Pouillon M, Robcis I, Sebban C, Fremont P, Belmin J. [Depression: an underrated consequence of stroke in elderly]. Psychol Neuropsychiatr Vieil 2005;3:7-16.
66 Alexopoulos GS, Kiosses DN, Klimstra S, Kalayam B, Bruce ML. Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am J Geriatr Psychiatry 2002;10:98-106.
67 Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54:915-922.   DOI   ScienceOn